Latest Breaking News On - Lucid psychss inc - Page 1 : comparemela.com

FSD Pharma : announces Interim Results from First-in-Human Clinical Trial of Lucid-MS (Lucid-21-302) for Multiple Sclerosis The Report Shows Compound to be Safe and Well Tolerated - Form 6-K -November 07, 2023 at 10:33 am EST

FSD Pharma announces Interim Results from First-in-Human Clinical Trial of Lucid-MS for Multiple Sclerosis. The Report Shows Compound to be Safe and Well Tolerated Toronto,.

United statesZeeshan saeedLakshmip kotraAndrzej chruscinskiScientific affairs at lucid psycheceuticalsBiopharma services incNational multiple sclerosis societyExchange commissionLucid psychss incNeither the canadian securities exchangeCompany annual report on formPharma incInterim resultsFirst in human clinical trialReport shows compoundMultiple sclerosis

FSD Pharma Inc : FSD Pharma and Celly Nu Enter Into Arrangement Agreement

FSD Pharma Inc : FSD Pharma and Celly Nu Enter Into Arrangement Agreement
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesJohn duffyPharma securityholdersZeeshan saeedPharma securityholderCompany or celly nuCanadian securities exchangePharma incLucid psychss incCelly nutrition corpPharma inc viewCelly nutritionClassb sharesCelly shareDistribution recordBusiness corporations act

FSD Pharma and Celly Nu Enter Into Arrangement Agreement

FSD Pharma and Celly Nu Enter Into Arrangement Agreement
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesPharma securityholderZeeshan saeedPharma securityholdersJohn duffyLucid psychss incCelly nutrition corpPharma incCanadian securities exchangeCompany or celly nuCelly nutritionClassb sharesCelly shareDistribution recordBusiness corporations actDistribution record date

FSD Pharma Inc : FSD Pharma Wins $2 8 Million Dollar Award Plus Accruing Interest from Dr Raza Bokhari; Set Aside Motion Brought by Bokhari, Now CEO of Medicus Pharma, Dismissed by the Ontario Superior Court of Justice

FSD Pharma Inc : FSD Pharma Wins $2 8 Million Dollar Award Plus Accruing Interest from Dr Raza Bokhari; Set Aside Motion Brought by Bokhari, Now CEO of Medicus Pharma, Dismissed by the Ontario Superior Court of Justice
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Zeeshan saeedRaza bokhariJ douglas cunninghamPharma inc viewLucid psychss incNeither the canadian securities exchangeMedicus pharma ltdCompany annual report on formJustice the courtExchange commissionOntario superior courtPharma incMedicus pharmaBryn mawrEmployment agreementPsychss inc

FSD Pharma Inc : FSD Pharma announces Interim Results from First-in-Human Clinical Trial of Lucid-MS for Multiple Sclerosis; The Report Shows Compound to be Safe and Well Tolerated

FSD Pharma Inc : FSD Pharma announces Interim Results from First-in-Human Clinical Trial of Lucid-MS for Multiple Sclerosis; The Report Shows Compound to be Safe and Well Tolerated
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesBaden wübergZeeshan saeedLakshmip kotraAndrzej chruscinskiNeither the canadian securities exchangeLucid psychss incExchange commissionBiopharma services incCompany annual report on formPharma incScientific affairs at lucid psycheceuticalsPharma inc viewNational multiple sclerosis societyMultiple sclerosisBiopharma services